Literature DB >> 28375876

Cochlear Implantation in Cases of Unilateral Hearing Loss: Initial Localization Abilities.

Margaret T Dillon1, Emily Buss, Meredith L Anderson, English R King, Ellen J Deres, Craig A Buchman, Kevin D Brown, Harold C Pillsbury.   

Abstract

OBJECTIVES: The present study evaluated early auditory localization abilities of cochlear implant (CI) recipients with normal or near-normal hearing (NH) in the contralateral ear. The goal of the study was to better understand the effect of CI listening experience on localization in this population.
DESIGN: Twenty participants with unilateral hearing loss enrolled in a prospective clinical trial assessing outcomes of cochlear implantation (ClinicalTrials.gov Identifier: NCT02203305). All participants received the MED-EL Standard electrode array, were fit with an ear-level audio processor, and listened with the FS4 coding strategy. Localization was assessed in the sound field using an 11-speaker array with speakers uniformly positioned on a horizontal, semicircular frame. Stimuli were 200-msec speech-shaped noise bursts. The intensity level (52, 62, and 72 dB SPL) and sound source were randomly interleaved across trials. Participants were tested preoperatively, and 1, 3, and 6 months after activation of the audio processor. Performance was evaluated in two conditions at each interval: (1) unaided (NH ear alone [NH-alone] condition), and (2) aided, with either a bone conduction hearing aid (preoperative interval; bone conduction hearing aid + NH condition) or a CI (postoperative intervals; CI + NH condition). Performance was evaluated by comparing root-mean-squared (RMS) error between listening conditions and between measurement intervals.
RESULTS: Mean RMS error for the soft, medium, and loud levels were 66°, 64°, and 69° in the NH-alone condition and 72°, 66°, and 70° in the bone conduction hearing aid + NH condition. Participants experienced a significant improvement in localization in the CI + NH condition at the 1-month interval (38°, 35°, and 38°) as compared with the preoperative NH-alone condition. Localization in the CI + NH condition continued to improve through the 6-month interval. Mean RMS errors were 28°, 25°, and 28° in the CI + NH condition at the 6-month interval.
CONCLUSIONS: Adult CI recipients with normal or near-normal hearing in the contralateral ear experienced significant improvement in localization after 1 month of device use, and continued to improve through the 6-month interval. The present results show that binaural acclimatization in CI users with unilateral hearing loss can progress rapidly, with marked improvements in performance observed after only 1 month of listening experience.

Entities:  

Mesh:

Year:  2017        PMID: 28375876     DOI: 10.1097/AUD.0000000000000430

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  17 in total

1.  One-Year Results for Patients with Unilateral Hearing Loss and Accompanying Severe Tinnitus and Hyperacusis Treated with a Cochlear Implant.

Authors:  Angel Ramos Macías; Juan Carlos Falcón-González; Manuel Manrique Rodríguez; Constantino Morera Pérez; Luis García-Ibáñez; Carlos Cenjor Español; Chrystelle Coudert-Koall; Matthijs Killian
Journal:  Audiol Neurootol       Date:  2018-06-21       Impact factor: 1.854

2.  Mechanisms of Localization and Speech Perception with Colocated and Spatially Separated Noise and Speech Maskers Under Single-Sided Deafness with a Cochlear Implant.

Authors:  Coral Dirks; Peggy B Nelson; Douglas P Sladen; Andrew J Oxenham
Journal:  Ear Hear       Date:  2019 Nov/Dec       Impact factor: 3.570

3.  Further Evidence for Individual Ear Consideration in Cochlear Implant Candidacy Evaluation.

Authors:  Ankita Patro; Nathan R Lindquist; Jourdan T Holder; Kareem O Tawfik; Matthew R O'Malley; Marc L Bennett; David S Haynes; René Gifford; Elizabeth L Perkins
Journal:  Otol Neurotol       Date:  2022-09-09       Impact factor: 2.619

4.  Benefits of Cochlear Implantation in Childhood Unilateral Hearing Loss (CUHL Trial).

Authors:  Kevin D Brown; Margaret T Dillon; Lisa R Park
Journal:  Laryngoscope       Date:  2021-09-20       Impact factor: 2.970

5.  Prevalence of Single-Sided Deafness in the United States.

Authors:  Emily Kay-Rivest; Alexandria L Irace; Justin S Golub; Mario A Svirsky
Journal:  Laryngoscope       Date:  2021-11-10       Impact factor: 2.970

6.  Restoration of spatial hearing in adult cochlear implant users with single-sided deafness.

Authors:  Ruth Y Litovsky; Keng Moua; Shelly Godar; Alan Kan; Sara M Misurelli; Daniel J Lee
Journal:  Hear Res       Date:  2018-04-14       Impact factor: 3.208

7.  Sound-localization performance of patients with single-sided deafness is not improved when listening with a bone-conduction device.

Authors:  Martijn J H Agterberg; Ad F M Snik; Rens M G Van de Goor; Myrthe K S Hol; A John Van Opstal
Journal:  Hear Res       Date:  2018-04-19       Impact factor: 3.208

8.  Effects of Cochlear Implantation on Binaural Hearing in Adults With Unilateral Hearing Loss.

Authors:  Emily Buss; Margaret T Dillon; Meredith A Rooth; English R King; Ellen J Deres; Craig A Buchman; Harold C Pillsbury; Kevin D Brown
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

9.  Influence of Cochlear Implant Use on Perceived Listening Effort in Adult and Pediatric Cases of Unilateral and Asymmetric Hearing Loss.

Authors:  Erin M Lopez; Margaret T Dillon; Lisa R Park; Meredith A Rooth; Margaret E Richter; Nicholas J Thompson; Brendan P O'Connell; Harold C Pillsbury; Kevin D Brown
Journal:  Otol Neurotol       Date:  2021-10-01       Impact factor: 2.619

10.  Low-Frequency Hearing Preservation With Long Electrode Arrays: Inclusion of Unaided Hearing Threshold Assessment in the Postoperative Test Battery.

Authors:  Margaret T Dillon; Emily Buss; Brendan P O'Connell; Meredith A Rooth; English R King; Andrea L Bucker; Ellen J Deres; Sarah A McCarthy; Harold C Pillsbury; Kevin D Brown
Journal:  Am J Audiol       Date:  2019-12-13       Impact factor: 1.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.